Literature DB >> 26187786

Excretory/secretory products of the carcinogenic liver fluke are endocytosed by human cholangiocytes and drive cell proliferation and IL6 production.

Sujittra Chaiyadet1, Michael Smout2, Michael Johnson3, Cynthia Whitchurch3, Lynne Turnbull3, Sasithorn Kaewkes4, Javier Sotillo2, Alex Loukas2, Banchob Sripa5.   

Abstract

Liver fluke infection caused by Opisthorchis viverrini remains a major public health problem in many parts of Asia including Thailand, Lao PDR, Vietnam and Cambodia, where there is a strikingly high incidence of cholangiocarcinoma (CCA - hepatic cancer of the bile duct epithelium). Among other factors, uptake of O. viverrini excretory/secretory products (OvES) by biliary epithelial cells has been postulated to be responsible for chronic inflammation and proliferation of cholangiocytes, but the mechanisms by which cells internalise O. viverrini excretory/secretory products are still unknown. Herein we incubated normal human cholangiocytes (H69), human cholangiocarcinoma cells (KKU-100, KKU-M156) and human colon cancer (Caco-2) cells with O. viverrini excretory/secretory products and analysed the effects of different endocytic inhibitors to address the mechanism of cellular uptake of ES proteins. Opisthorchis viverrini excretory/secretory products was internalised preferentially by liver cell lines, and most efficiently/rapidly by H69 cells. There was no evidence for trafficking of ES proteins to cholangiocyte organelles, and most of the fluorescence was detected in the cytoplasm. Pretreatment with clathrin inhibitors significantly reduced the uptake of O. viverrini excretory/secretory products, particularly by H69 cells. Opisthorchis viverrini excretory/secretory products induced proliferation of liver cells (H69 and CCA lines) but not intestinal (Caco-2) cells, and proliferation was blocked using inhibitors of the classical endocytic pathways (clathrin and caveolae). Opisthorchis viverrini excretory/secretory products drove IL6 secretion by H69 cells but not Caco-2 cells, and cytokine secretion was significantly reduced by endocytosis inhibitors. This the first known study to address the endocytosis of helminth ES proteins by host epithelial cells and sheds light on the pathways by which this parasite causes one of the most devastating forms of cancer in south-eastern Asia.
Copyright © 2015 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Cholangiocyte; Endocytosis; Excretory/secretory products; IL6; Opisthorchis viverrini

Mesh:

Substances:

Year:  2015        PMID: 26187786      PMCID: PMC4912216          DOI: 10.1016/j.ijpara.2015.06.001

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  40 in total

Review 1.  Innate mechanisms of epithelial host defense: spotlight on intestine.

Authors:  G Hecht
Journal:  Am J Physiol       Date:  1999-09

2.  Analysis of Opisthorchis viverrini antigens by immunoprecipitation and polyacrylamide gel electrophoresis.

Authors:  S Wongratanacheewin; R Chawengkirttikul; D Bunnag; S Sirisinha
Journal:  Parasitology       Date:  1988-02       Impact factor: 3.234

3.  The chameleon within: improving antigen delivery.

Authors:  J L Madara
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover.

Authors:  Gianni M Di Guglielmo; Christine Le Roy; Anne F Goodfellow; Jeffrey L Wrana
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

Review 5.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

Review 6.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

7.  Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.

Authors:  Banchob Sripa; Bandit Thinkhamrop; Eimorn Mairiang; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Maria Victoria Periago; Vajarabhongsa Bhudhisawasdi; Ponlapat Yonglitthipagon; Jason Mulvenna; Paul J Brindley; Alex Loukas; Jeffrey M Bethony
Journal:  PLoS Negl Trop Dis       Date:  2012-05-22

8.  Cathepsin F cysteine protease of the human liver fluke, Opisthorchis viverrini.

Authors:  Porntip Pinlaor; Natthawut Kaewpitoon; Thewarach Laha; Banchob Sripa; Sasithorn Kaewkes; Maria E Morales; Victoria H Mann; Sandi K Parriott; Sutas Suttiprapa; Mark W Robinson; Joyce To; John P Dalton; Alex Loukas; Paul J Brindley
Journal:  PLoS Negl Trop Dis       Date:  2009-03-24

9.  Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Thewarach Laha; Porntip Pinlaor; Jason Mulvenna; Banchob Sripa; Manop Sripa; Michael J Smout; Robin B Gasser; Paul J Brindley; Alex Loukas
Journal:  BMC Genomics       Date:  2007-06-22       Impact factor: 3.969

10.  Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules.

Authors:  J E Schnitzer; P Oh; E Pinney; J Allard
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  17 in total

1.  Proteomic characterization of the internalization of Opisthorchis viverrini excretory/secretory products in human cells.

Authors:  Sujittra Chaiyadet; Michael Smout; Thewarach Laha; Banchob Sripa; Alex Loukas; Javier Sotillo
Journal:  Parasitol Int       Date:  2016-02-09       Impact factor: 2.230

Review 2.  Liver fluke infection and cholangiocarcinoma: a review.

Authors:  Shuohan Zheng; Yuan Zhu; Zijun Zhao; Zhongdao Wu; Kamolnetr Okanurak; Zhiyue Lv
Journal:  Parasitol Res       Date:  2016-10-08       Impact factor: 2.289

Review 3.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

4.  Suppression of mRNAs encoding CD63 family tetraspanins from the carcinogenic liver fluke Opisthorchis viverrini results in distinct tegument phenotypes.

Authors:  Sujittra Chaiyadet; Watchara Krueajampa; Wiphawi Hipkaeo; Yada Plosan; Supawadee Piratae; Javier Sotillo; Michael Smout; Banchob Sripa; Paul J Brindley; Alex Loukas; Thewarach Laha
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

5.  Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.

Authors:  Arpa Surapaitoon; Sutas Suttiprapa; Eimorn Mairiang; Narong Khuntikeo; Chawalit Pairojkul; Jeffrey Bethony; Paul J Brindley; Banchob Sripa
Journal:  Korean J Parasitol       Date:  2017-06-30       Impact factor: 1.341

6.  Extracellular Vesicles from a Helminth Parasite Suppress Macrophage Activation and Constitute an Effective Vaccine for Protective Immunity.

Authors:  Gillian Coakley; Jana L McCaskill; Jessica G Borger; Fabio Simbari; Elaine Robertson; Marissa Millar; Yvonne Harcus; Henry J McSorley; Rick M Maizels; Amy H Buck
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

7.  Extracellular vesicles and vesicle-free secretome of the protozoa Acanthamoeba castellanii under homeostasis and nutritional stress and their damaging potential to host cells.

Authors:  Diego de Souza Gonçalves; Marina da Silva Ferreira; Susie Coutinho Liedke; Kamilla Xavier Gomes; Gabriel Afonso de Oliveira; Pedro Ernesto Lopes Leão; Gabriele Vargas Cesar; Sergio H Seabra; Juliana Reis Cortines; Arturo Casadevall; Leonardo Nimrichter; Gilberto Barbosa Domont; Magno Rodrigues Junqueira; Jose Mauro Peralta; Allan J Guimaraes
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

Review 8.  Liver Fluke-Associated Biliary Tract Cancer.

Authors:  Piyapan Prueksapanich; Panida Piyachaturawat; Prapimphan Aumpansub; Wiriyaporn Ridtitid; Roongruedee Chaiteerakij; Rungsun Rerknimitr
Journal:  Gut Liver       Date:  2018-05-15       Impact factor: 4.519

Review 9.  Parasite Infection, Carcinogenesis and Human Malignancy.

Authors:  Hoang van Tong; Paul J Brindley; Christian G Meyer; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-12-02       Impact factor: 8.143

10.  Granulin Expression in Hamsters during Opisthorchis viverrini Infection-Induced Cholangiocarcinogenesis

Authors:  Songkiad Upontain; Piya Sereerak; Thewarach Laha; Banchob Sripa; Prasarn Tangkawatana; Paul J Brindley; Sirikachorn Tangkawatana
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.